Fat-binding polymers

Details Fat-binding polymers Fat-binding polymers

2006-05-23

2006-05-23

Wang, Shengjun (Department: 1617)

Drug, bio-affecting and body treating compositions

Solid synthetic organic polymer as designated organic active...

Polymer from ethylenic monomers only

C424S078010, C424S078360, C424S078310, C514S449000, C514S909000

Reexamination Certificate

active

07048917

ABSTRACT:
The present invention relates to a method for treating obesity, a method for reducing the absorption of dietary fat, and a method for treating hypertriglyceridemia in a patient and to particular polymers for use in the methods or in a manufacture of a medicament. The methods comprise the step of orally administering to a mammal, such as a human, a therapeutically effective amount of one or more fat-binding polymers. The administration of the fat-binding polymer of the invention facilitates the removal of fat from the body prior to digestion, with minimal side effects and low toxicity. In a preferred embodiment, the one or more fat-binding polymers are administered in combination with one or more lipase inhibitors, for example, lipstatin and tetrahydrolipstatin.

REFERENCES:
patent: 3780171 (1973-12-01), Irmscher et al.
patent: 3923972 (1975-12-01), Fields et al.
patent: 4160826 (1979-07-01), Fischetti
patent: 4211765 (1980-07-01), Johnson et al.
patent: 4218443 (1980-08-01), Comai et al.
patent: 4265879 (1981-05-01), Fields et al.
patent: 4302450 (1981-11-01), Comai et al.
patent: 4432968 (1984-02-01), Page et al.
patent: 4598089 (1986-07-01), Hadvary et al.
patent: 4959179 (1990-09-01), Aronson et al.
patent: 5063210 (1991-11-01), Lange, III et al.
patent: 5089163 (1992-02-01), Aronson et al.
patent: 5137716 (1992-08-01), Weisenfeld
patent: 5200183 (1993-04-01), Tang et al.
patent: 5286481 (1994-02-01), Weisenfeld
patent: 5308766 (1994-05-01), Dennis et al.
patent: 5376674 (1994-12-01), Derungs et al.
patent: 5401498 (1995-03-01), Kesseler et al.
patent: 5427919 (1995-06-01), Dennis et al.
patent: 5453282 (1995-09-01), Kanauchi et al.
patent: 5453429 (1995-09-01), Bliem et al.
patent: 5474993 (1995-12-01), Rubin et al.
patent: 5484777 (1996-01-01), Lange, III et al.
patent: 5567597 (1996-10-01), Dennis et al.
patent: 5569452 (1996-10-01), Amidon et al.
patent: 5597810 (1997-01-01), Hoffman et al.
patent: 5607669 (1997-03-01), Mandeville, III et al.
patent: 5618530 (1997-04-01), Mandeville, III et al.
patent: 5624963 (1997-04-01), Mandeville, III et al.
patent: 5665348 (1997-09-01), Okayama et al.
patent: 5679717 (1997-10-01), Mandeville, III et al.
patent: 5693675 (1997-12-01), Mandeville, III et al.
patent: 5703188 (1997-12-01), Mandeville, III et al.
patent: 5750524 (1998-05-01), Mera et al.
patent: 5900233 (1999-05-01), Day
patent: 5900475 (1999-05-01), Mandeville, III et al.
patent: 6030953 (2000-02-01), Bailly et al.
patent: 6299868 (2001-10-01), Jozefiak et al.
patent: 6358522 (2002-03-01), Hug et al.
patent: 0 050 347 (1982-04-01), None
patent: 0 381 262 (1990-08-01), None
patent: 2 081 400 (1971-12-01), None
patent: 04333694 (1992-11-01), None
patent: 06 321787 (1994-11-01), None
patent: WO 89/07455 (1989-08-01), None
CAPLUS Abstract, AN 1993:256861, JP 04333694, 1992, Niike et al.
CAS registry 147867-87-6.
Gargouri, Y., et al., “Ajoene prevents fat digestion by human gastric lipasein vitro,” Biochimica et Biophysica Acta. 1006:137-139 (1989).
Gargouri, Y., et al., “Covalent inhibition of digestive lipases: anin vitrostudy,”Biochimica et Biophysica Acta. 1344:6-37 (1997).
Karamać, M. and Amarowicz, R., “Inhibition of Pancreatic Lipase by Phenolic Acids, Examinationin vitro,” Verlag der Zeitschrift für Naturforschung:903-905 (1996).
Marguet, F., et al., “Digestive lipases: inactivation by phosphonates,”Biochimica et Biophysica Acta. 1210:157-166 (1994).
Mannesse, M.L.M., et al., “Phosphonate analogues of triacylglycerols are potent inhibitors of lipase,”Biochimica et Biophysica Acta. 1259:56-64 (1995).
Martichonok, V. and Jones, J.B., “(Z)-Heptadec-8-enylboronic acid: a potential lipase inhibitor,”J. Chem. Soc. Perkin Trans. I:2927-2929 (1995).
Vainio, P., et al., “Inhibition of Lipoprotein Lipase by Benzene Boronic Acid Effect of Apolipoprotein C-II,”Biochimica et Biophysica Acta. 711:386-390 (1982).
Bagree, A., et al., “Modification of ε-Amino Group of Lysine in Proteins by Acylation with Pyromellitic Dianhydride ando-Sulphobenzoic Anhydride,”FEBS Letters120 (2):275-277 (1980).
Stadler, P., et al., “Inhibition of microbial lipases with stereoisomeric triradylglycerol analog phosphonates,”Biochimica et Biophysica Acta. 1304:229-244 (1996).
Kawaguchi, K., et al. Hesperidin as an Inhibitor of Lipases from Procine Pancreas andPseudomonas, Biosci. Biotech. Biochem. 61(1):102-104 (1997).
Bochenek, W.J. and Rodgers, J.B., “Effect of Polyol Detergents on Cholesterol and Triglyceride Absorption,”Biochimica et Biophysica Acta 489:503-506 (1977).
Comai, K. and Sullivan, A.C., “Antiobesity activity of pluronic L-101,”International Journal of Obesity 4:33-42 (1980).
Han, L-K, et al., “Reduction in fat storage during chitin-chitosan treatment in mice fed a high-fat diet,”International Journal of Obesity 23:174-179 (1999).
Atkinson, et al., “Combined drug treatment of obesity,”Obesity Research,vol. 3, No. S4:497S-500S (1995).
Sjöström, et al., “Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients,”The Lancet,352:167-172 (1998).

Affiliated with

Also associated with

Rating

Fat-binding polymers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fat-binding polymers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fat-binding polymers will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3635598